CDKN2A and glioma: Particularly, FOXM1B was demonstrated to promote angiogenesis, tumor growth of glioma cells and metastasis of HCC in the absence of Arf while FOXM1C was found to enhance cell growth and anchorage-independent ability of cervical cancer cells [6], [7], [15], [16].